Ecolab (ECL)
(Delayed Data from NYSE)
$247.23 USD
+1.00 (0.41%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $247.10 -0.13 (-0.05%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth C Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$247.23 USD
+1.00 (0.41%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $247.10 -0.13 (-0.05%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth C Momentum C VGM
Zacks News
Should You Invest in the Fidelity MSCI Materials Index ETF (FMAT)?
by Zacks Equity Research
Sector ETF report for FMAT
ICL vs. ECL: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
ICL vs. ECL: Which Stock Is the Better Value Option?
Ecolab (ECL) Earnings and Revenues Match Estimates in Q4
by Zacks Equity Research
Ecolab (ECL) sees solid segmental gains in Q4.
Ecolab (ECL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Ecolab (ECL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Can Global Industrial Unit Aid Ecolab's (ECL) Q4 Earnings?
by Zacks Equity Research
Ecolab's (ECL) preliminary Q4 earnings are likely to fall short of estimates.
Ecolab (ECL) Reports Preliminary Q4 Results, Issues Guidance
by Zacks Equity Research
Ecolab (ECL) plans to spin off Upstream Energy sub-unit as a stand-alone publicly-traded company by mid-2020.
The Zacks Analyst Blog Highlights: Procter & Gamble, NVIDIA, Bristol-Myers, Deere and Ecolab
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Procter & Gamble, NVIDIA, Bristol-Myers, Deere and Ecolab
Top Analyst Reports for Procter & Gamble, NVIDIA & Bristol-Myers
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Procter & Gamble (PG), NVIDIA (NVDA) and Bristol-Myers (BMY).
Top Research Reports for Morgan Stanley, Intuitive Surgical & Colgate-Palmolive
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, Morgan Stanley (MS), Intuitive Surgical, Inc. (ISRG) and Colgate-Palmolive Company (CL).
Ecolab Inks Deal With Clearway for Renewable Power Project
by Zacks Equity Research
Ecolab's (ECL) virtual power purchase agreement with Clearway is part of a broader trend among corporate buyers. This will cover the company???s annual domestic energy use completely.
The Zacks Analyst Blog Highlights: Eli Lilly, Mitsubishi UFJ, Thermo Fisher, Oracle and Ecolab
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Eli Lilly, Mitsubishi UFJ, Thermo Fisher, Oracle and Ecolab
Top Analyst Reports for Eli Lilly, Mitsubishi UFJ & Thermo Fisher
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), Mitsubishi UFJ Financial Group, Inc. (MUFG) and Thermo Fisher Scientific Inc. (TMO).
Ecolab to Boost Food Safety Standards With Holchem Buyout
by Zacks Equity Research
Ecolab (ECL) to benefit from Holchem Group's unique offerings for the food and beverage, foodservice and hospitality industries.
Stock Market News For Dec 3, 2018
by Zacks Equity Research
Wall Street closed firmly higher on Friday on investor's hopes of a possible truce in the eight-month old trade conflict between the United States and China
Ecolab to Buy Bioquell for Healthcare & Life Sciences' Growth
by Zacks Equity Research
Ecolab (ECL) to leverage on Bioquell's innovative bio-decontamination and isolator platforms for residue-free surface decontamination.
Ecolab (ECL) Up 2% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Ecolab (ECL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Material ETFs Gain on Q3 Earnings
by Sweta Killa
Given the solid results, the material sector is up 2.5% in response to earnings announcements. The positive trading has also pushed material ETFs higher over the past month.
The Zacks Analyst Blog Highlights: Verizon, Express Scripts, Cigna, Ecolab and eBay
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Verizon, Express Scripts, Cigna, Ecolab and eBay
Top Stock Reports for Verizon, Express Scripts & Cigna
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Verizon (VZ), Express Scripts (ESRX), and Cigna (CI).
Ecolab (ECL) Misses on Q3 Earnings & Revenues, Lowers View
by Zacks Equity Research
Ecolab (ECL) misses estimates despite strong growth in Global Industrial and Global Institutional; 2018 guidance dull.
Ecolab (ECL) Lags Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Ecolab (ECL) delivered earnings and revenue surprises of -1.29% and -0.69%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Ecolab (ECL) Q3 Earnings Preview: What to Know Ahead of the Release
by Zacks Equity Research
Ecolab (ECL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Will Global Industrial Unit Boost Ecolab's (ECL) Q3 Earnings?
by Zacks Equity Research
Solid performance in the Global Industrial segment to drive Ecolab's (ECL) Q3 results.
The Zacks Analyst Blog Highlights: Altria, U.S. Bancorp, Biogen, Ecolab and HSBC
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Altria, U.S. Bancorp, Biogen, Ecolab and HSBC
International Paper Announces Share Buyback, Hikes Dividend
by Zacks Equity Research
International Paper (IP) aims to utilize its sound cash flow by investing in capital projects, reducing its total debt and returning a greater proportion of cash to shareholders.